Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG).

IF 3.5 3区 医学 Q3 INFECTIOUS DISEASES
Jon Salmanton-García, Katrien Lagrou, Fanny Lanternier, Malcolm Richardson, Robina Aerts, Antonio Vena
{"title":"Profiling medical mycologists: Results from a global survey of the ESCMID Fungal Infection Study Group (EFISG).","authors":"Jon Salmanton-García, Katrien Lagrou, Fanny Lanternier, Malcolm Richardson, Robina Aerts, Antonio Vena","doi":"10.1093/mmy/myag037","DOIUrl":null,"url":null,"abstract":"<p><p>Invasive fungal infections are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasing antifungal resistance, unequal access to diagnostics and therapies, and complex host-pathogen interactions highlight the need for coordinated research. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) addresses these challenges by promoting multidisciplinary collaboration and advancing research and education in medical mycology. This study aimed to characterize the global medical mycology workforce using EFISG as a representative international network. A cross-sectional survey was conducted among EFISG members between June and December 2025. The survey collected data on demographics, geographic distribution, professional background, career stage, research interests, language proficiency, and involvement in other scientific societies and ESCMID study groups. A total of 342 members from 72 countries responded, representing two-thirds of all countries with EFISG membership. Most participants were based in Europe (60%). Sex distribution was balanced, and all career stages were included, with 22.8% early-career professionals and 14.6% trainees. Key research interests included epidemiology of fungal infections (68.4%), mycoses in immunocompromised hosts (67.5%), development of diagnostic methods (54.4%), and rare and emerging fungal diseases (54.1%). Infectious disease specialists (52.3%) and microbiologists (42.4%) comprised the majority of respondents, and most reported active participation in other ESCMID study groups and scientific societies. These findings provide the first structured overview of the medical mycology workforce, identifying gaps in representation, training, and emerging research areas, with implications for global capacity building, collaboration, and strategic planning beyond EFISG.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myag037","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Invasive fungal infections are a major cause of morbi-mortality, particularly in immunocompromised and critically ill patients. Increasing antifungal resistance, unequal access to diagnostics and therapies, and complex host-pathogen interactions highlight the need for coordinated research. The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) addresses these challenges by promoting multidisciplinary collaboration and advancing research and education in medical mycology. This study aimed to characterize the global medical mycology workforce using EFISG as a representative international network. A cross-sectional survey was conducted among EFISG members between June and December 2025. The survey collected data on demographics, geographic distribution, professional background, career stage, research interests, language proficiency, and involvement in other scientific societies and ESCMID study groups. A total of 342 members from 72 countries responded, representing two-thirds of all countries with EFISG membership. Most participants were based in Europe (60%). Sex distribution was balanced, and all career stages were included, with 22.8% early-career professionals and 14.6% trainees. Key research interests included epidemiology of fungal infections (68.4%), mycoses in immunocompromised hosts (67.5%), development of diagnostic methods (54.4%), and rare and emerging fungal diseases (54.1%). Infectious disease specialists (52.3%) and microbiologists (42.4%) comprised the majority of respondents, and most reported active participation in other ESCMID study groups and scientific societies. These findings provide the first structured overview of the medical mycology workforce, identifying gaps in representation, training, and emerging research areas, with implications for global capacity building, collaboration, and strategic planning beyond EFISG.

分析医学真菌学家:来自ESCMID真菌感染研究组(EFISG)的全球调查结果。
侵袭性真菌感染(IFI)是发病-死亡的主要原因,特别是在免疫功能低下和危重患者中。抗真菌药物耐药性的增加、诊断和治疗的不平等获得以及复杂的宿主-病原体相互作用突出了协调研究的必要性。欧洲临床微生物学和传染病学会(ESCMID)真菌感染研究组(EFISG)通过促进多学科合作和推进医学真菌学的研究和教育来应对这些挑战。本研究旨在利用EFISG作为具有代表性的国际网络来描述全球医学真菌学工作人员的特征。在2025年6月至12月期间,对EFISG成员进行了横断面调查。调查收集了人口统计、地理分布、专业背景、职业阶段、研究兴趣、语言熟练程度以及参与其他科学学会和ESCMID研究小组的数据。来自72个国家的342个成员作出了答复,占EFISG所有成员国家的三分之二。大多数参与者来自欧洲(60%)。性别分布均衡,包括所有职业阶段,职业早期专业人员占22.8%,培训生占14.6%。主要研究方向包括真菌感染流行病学(68.4%)、免疫功能低下宿主真菌病(67.5%)、诊断方法发展(54.4%)和罕见和新发真菌病(54.1%)。传染病专家(52.3%)和微生物学家(42.4%)占答复者的大多数,而且大多数报告积极参加了其他ESCMID研究组和科学学会。这些发现首次提供了医学真菌学工作人员的结构化概述,确定了代表性、培训和新兴研究领域方面的差距,并对EFISG之外的全球能力建设、合作和战略规划产生了影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Medical mycology
Medical mycology 医学-兽医学
CiteScore
5.70
自引率
3.40%
发文量
632
审稿时长
12 months
期刊介绍: Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书